目次

TABLE OF CONTENTS

1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
1.7.1 RECESSION IMPACT

2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
2.2 MARKET ESTIMATION METHODOLOGY
2.3 MARKET GROWTH RATE PROJECTIONS
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5 PRIMARY INSIGHTS
2.6 RESEARCH ASSUMPTIONS
2.6.1 IMPACT OF RECESSION
2.7 RISK ANALYSIS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET SEGMENTATION
5.3 MARKET DYNAMICS
5.3.1 DRIVERS
5.3.2 RESTRAINTS
5.3.3 OPPORTUNITIES
5.3.3 CHALLENGES
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.5 PRICING ANALYSIS
5.6 TECHNOLOGY ANALYSIS
5.7 VALUE CHAIN ANALYSIS
5.8 SUPPLY CHAIN ANALYSIS
5.9 ECOSYSTEM ANALYSIS OF CELL THERAPY TECHNOLOGIES MARKET
5.10 KEY CONFERENCES AND EVENTS IN 2023-2024
5.11 REGULATORY ANALYSIS
5.12 PORTER’S FIVE FORCES ANALYSIS
5.12.1 THREAT FROM NEW ENTRANTS
5.12.2 THREAT OF SUBSITITUTE
5.12.3 BARGAINING POWER OF SUPPLERS
5.12.4 BARGAINING POWER OF BUYERS
5.12.5 INTENSITY OF COMPETITION RIVARLY
5.13 PATENT ANALYSIS
5.14 KEY STAKEHOLDERS AND BUYING CRITERIA

6 CELL THERAPY TECHNOLOGIES MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 MEDIA, SERA, AND REAGENTS
6.3 CELL ENGINEERING PRODUCTS
6.4 CELL CULTURE VESSELS
6.5 EQUIPMENT
6.5.1 CELL PROCESSING EQUIPMENT
6.5.2 SINGLE-USE EQUIPMENT
6.5.3 OTHER EQUIPMENTS
6.6 SYSTEMS AND SOFTWARE
6.7 OTHER PRODUCTS7

7 CELL THERAPY TECHNOLOGIES MARKET, BY PROCESS
7.1 INTRODUCTION
7.2 CELL PROCESSING
7.3 CELL PRESERVATION, DISTRIBUTION, AND HANDLING
7.4 PROCESS MONITORING AND QUALITY CONTROL

8 CELL THERAPY TECHNOLOGIES MARKET, BY CELL TYPE
8.1 INTRODUCTION
8.2 T-CELLS
8.3 STEM CELLS
8.4 OTHER CELLS

9 CELL THERAPY TECHNOLOGIES MARKET, BY END USER
9.1 INTRODUCTION
9.2 BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
9.3 CROS & CMOS
9.4 RESEARCH INSTITUTES & CELL BANKS

10 CELL THERAPY TECHNOLOGIES MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 US
10.2.2 CANADA
10.2.3 RECESSION IMPACT
10.3 EUROPE
10.3.1 GERMANY
10.3.2 UK
10.3.3 FRANCE
10.3.4 REST OF EUROPE
10.3.5 RECESSION IMPACT
10.4 ASIA PACIFIC
10.4.1 JAPAN
10.4.2 CHINA
10.4.3 INDIA
10.4.4 REST OF APAC
10.4.5 RECESSION IMPACT
10.5 REST OF WORLD (ROW)
10.5.1 LATIN AMERICA
10.5.2 MIDDLE EAST AND AFRICA
10.5.3 RECESSION IMPACT

11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION
11.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS
11.3 MARKET SHARE ANALYSIS (2022)
11.4 REVENUE SHARE ANALYSIS
11.5 COMPANY EVALUATION QUADRANT: TOP 25 PLAYERS
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 EMERGING COMPANIES
11.6 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS
11.6.1 COMPANY PRODUCT FOOTPRINT ANALYSIS
11.6.2 COMPANY GEOGRAPHIC FOOTPRINT
11.7 COMPANY EVALUATION QUADRANT: START-UPS/SMES
11.7.1 PROGRESSIVE COMPANIES
11.7.2 STARTING BLOCKS
11.7.3 RESPONSIVE COMPANIES
11.7.4 DYNAMIC COMPANIES
11.8 COMPETATIVE BENCHMARKING OF STARTUP
11.9 COMPETITIVE SCENARIO AND TRENDS
11.9.1 PRODUCT LAUNCHES
11.9.2 DEALS
11.9.3 OTHERS DEVELOPMENT

12 COMPANY PROFILES
12.1 KEY PLAYERS
12.1.1 THERMO FISHER SCIENTIFIC, INC.
12.1.2 MERCK KGAA
12.1.3 DANAHER CORPORATION
12.1.4 LONZA GROUP
12.1.5 SARTORIUS AG
12.1.6 TERUMO BCT, INC.
12.1.7 BECTON, DICKINSON AND COMPANY
12.1.8 FRESENIUS SE & CO. KGAA
12.1.9 AVANTOR, INC.
12.1.10 BIO-TECHNE CORPORATION
12.1.11 CORNING INCORPORATED
12.1.12 FUJIFILM IRVINE SCIENTIFIC
12.2 OTHER COMPANIES
12.1.1 WERUM IT SOLUTIONS
12.2.2 ROOSTERBIO, INC.
12.2.3 SIRION BIOTECH GMBH
12.2.4 TRAKCEL
12.2.5 L7 INFORMATICS
12.2.6 MILTENYI BIOTEC
12.2.7 STEMCELL TECHNOLOGIES INC
12.2.8 GPI IBERIA (FORMERLY HEMASOFT)
12.2.9 MAK-SYSTEM
12.3.10 ORGANABIO, LLC
12.3.11 IXCELLS BIOTECHNOLOGY
12.2.12 WILSON WOLF MANUFACTURING CORPORATION

13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 AVAILABLE CUSTOMIZATIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS